Savara SVRA
NASDAQ SVRA
$4.22 -0.32 (-7.05%)
At close: Oct 23, 2026 · 4:00 PM EDT

Savara (SVRA) Gains from Investment Securities (2016 - 2020)

Updated

Analysis

Savara (SVRA) Gains from Investment Securities (2016 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Savara 866.79 Mn 130.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 60,000.00
Jun 30, 2020 54,000.00
Mar 31, 2020 2,000.00
Dec 31, 2019 41,000.00
Sep 30, 2019 -136,000.00
Jun 30, 2019 -41,000.00
Mar 31, 2019 -77,000.00
Dec 31, 2018 -12,000.00
Sep 30, 2018 10,000.00
Jun 30, 2018 34,000.00
Mar 31, 2018 -96,000.00
Sep 30, 2017 -43,000.00
Jun 30, 2017 -177,000.00
Mar 31, 2017 -60,000.00
Dec 31, 2016 91,000.00
Sep 30, 2016 101,000.00
Jun 30, 2016 23,000.00
API Access

Savara Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=SVRA&period=max&api_key=YOUR_API_KEY